Stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.

Vaccines and other policies could help keep in check a disease that’s becoming increasingly common worldwide.

Using next-generation sequencing, the UPSeq test assesses 15 biomarkers to find aggressive prostate cancer that can be missed by biopsies or imaging tests.

MiTF renal cell carcinoma can masquerade as other subtypes and may not respond as well to front-line therapies.

Study findings support the recent FDA approval of the immunotherapy agent for patients whose cancers have high number of mutations.

Scientists have long sought to target the interaction between the proteins p53 and Mdm2 in tumor cells, but their interaction in immune cells may be just as important.